Sender Company & Partners’s Astera Labs ALAB Stock Holding History

Sender Company & Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,585	Closed	-$506K	–	464
2025 Q3	$506K	Buy	+2,585	New	+$425K	0.06%	255

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Sender Company & Partners's ALAB Position: Q4 2025 in Review

Sender Company & Partners sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 2,585 shares — an estimated $506K sold.

Sender Company & Partners first reported a position in ALAB in Q3 2025 and held it in 1 quarter. The position peaked at $506K in Q3 2025. 700 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

Sender Company & Partners reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
Sender Company & Partners sold 2,585 Astera Labs shares in Q4 2025, an estimated $506K.
Sender Company & Partners first reported a position in Astera Labs in Q3 2025 and held it in 1 quarter.
Sender Company & Partners's Astera Labs position peaked at $506K in Q3 2025.
700 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Sender Company & Partners's 13F filing for Q4 2025, filed 17 Feb 2026.